Magazine Article | September 8, 2017

Behind The Scenes Of Allergan's Social Contract

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

"Allergan CEO fires back on Hillary Clinton tweet.”

That’s how CNBC titled an interview between Brent Saunders, Allergan’s chairman, president, and CEO, and Mad Money host Jim Cramer back on September 21, 2015. The tweet in question, referencing Turing Pharmaceuticals’ significant price increase of a 62-year-old drug, read:

THIS CONTENT IS EXCLUSIVELY FOR LIFE SCIENCE LEADER PAID SUBSCRIBERS.
To continue reading this story and receive uninterrupted access to LSL Online and its monthly magazine subscribe to Life Science Leader today!
Already a subscriber? Log in now.